Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, 100 Eglantine Driveway, Ottawa, Ontario K1A 0K9, Canada.
Prev Med. 2014 Jan;58:1-8. doi: 10.1016/j.ypmed.2013.10.002. Epub 2013 Oct 18.
We aimed to assess the potential prevention benefits of HIV treatment as prevention (TasP) in resource-rich countries and examine the potential interactions between TasP and other prevention strategies by reviewing mathematical models of TasP.
Multiple databases were searched for mathematical models published in the previous 5 years (from July 2007 to July 2012). The nine models located were set in Canada, Australia and the United States.
These models' predictions suggested that the impact of expanding treatment rates on expected new infections could range widely, from no decrease to a decrease of 76%, depending on the time horizon, assumptions and the form of TasP modeled. Increased testing, reducing sexually transmitted infections and reducing risky practices were also predicted to be important strategies for decreasing expected new infections. Sensitivity analysis suggests that current uncertainties such as the effectiveness of highly active antiretroviral therapy outside of heterosexual transmission, less than ideal adherence, and risk compensation, could impact on the success of TasP at the population level.
The results from large scale pilots and community randomized controlled trials will be useful in demonstrating how well this prevention approach works in real world settings, and in identifying the factors that are needed to support its effectiveness.
我们旨在评估资源丰富国家中 HIV 治疗即预防(TasP)的潜在预防效益,并通过审查 TasP 的数学模型来研究 TasP 与其他预防策略之间的潜在相互作用。
在过去 5 年(2007 年 7 月至 2012 年 7 月)中,从多个数据库中搜索发表的数学模型。定位到的 9 个模型分别位于加拿大、澳大利亚和美国。
这些模型的预测表明,扩大治疗率对预期新感染的影响范围很广,从没有减少到减少 76%,具体取决于时间范围、假设和建模的 TasP 形式。增加检测、减少性传播感染和减少危险行为也被预测为减少预期新感染的重要策略。敏感性分析表明,目前的不确定性,如异性传播之外的高效抗逆转录病毒疗法的有效性、不理想的依从性和风险补偿,可能会影响 TasP 在人群层面的成功。
大规模试点和社区随机对照试验的结果将有助于展示这种预防方法在实际环境中的效果如何,并确定支持其有效性所需的因素。